Vitiligo: To treat or not to treat

Archives of Dermatology

Volumn 143, Issue 5, 2007, Pages 643-646

  Lim, Henry W ^a   Hexsel, Camile L ^b  

^a HENRY FORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CALCIPOTRIOL; CLOBETASOL; DIHYDROXYACETONE; HYDROQUINONE; METHOXSALEN; METHYLPREDNISOLONE; TACROLIMUS; TRIAMCINOLONE;

BODY SURFACE; CLINICAL TRIAL; HUMAN; LOW LEVEL LASER THERAPY; PHOTOTHERAPY; PRIORITY JOURNAL; PUVA; REVIEW; SKIN ATROPHY; SKIN GRAFT; SKIN PIGMENTATION; SOCIAL SUPPORT; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT; VITILIGO;

DERMATOLOGIC AGENTS; HUMANS; PHOTOTHERAPY; SKIN TRANSPLANTATION; TREATMENT OUTCOME; VITILIGO;

EID: 34249088891     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.143.5.643     Document Type: Review

References (21)

1. Kovacs SO. Vitiligo. J Am Acad Dermatol. 1998;38:647-668.
2. Yones SS, Palmer RA, Garibaldinos TM, Hawk JLM. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs narrowband-UV-B therapy. Arch Dermatol. 2007;143:578-584.
3. Passeron T, Ostovari N, Zakaria W, et al. Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. Arch Dermatol. 2004;140:1065-1069.
4. Hofer A, Hassan AS, Legat FJ, Kerl H, Wolf P. Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients. Br J Dermatol. 2005;152:981-985.
5. Hadi SM, Spencer JM, Lebwohl M. The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg. 2004;30:983-986.
6. Kandil E. Treatment of vitiligo with 0-1 percent betamethasone 17-valerate in isopropyl alcohol: a double-blind trial. Br J Dermatol. 1974;91:457-460.
7. Vasistha LK, Singh G. Vitiligo and intralesional steroids. Indian J Med Res. 1979;69:308-311.
8. Seiter S, Ugurel S, Tilgen W, Reinhold U. Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo. Int J Dermatol. 2000;39:624-627.
9. Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol. 2003;139:581-585.
10. Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol. 2004;51:52-61.
11. Kumaran MS, Kaur I, Kumar B. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol. 2006;20:269-273.
12. Arca E, Tastan HB, Erbil AH, Sezer E, Koc E, Kurumlu Z. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol. 2006;33:338-343.
13. Kullavanijaya P, Lim HW. Topical calcipotriene and narrowband ultraviolet B in the treatment of vitiligo. Photodermatol Photoimmunol Photomed. 2004;20:248-251.
14. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? a placebo-controlled double-blind study. Br J Dermatol. 2001;145:472-475.
15. Mosher DB, Parrish JA, Fitzpatrick TB. Monobenzylether of hydroquinone: a retrospective study of treatment of 18 vitiligo patients and a review of the literature. Br J Dermatol. 1977;97:669-679.
16. Njoo MD, Vodegel RM, Westerhof W. Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser. J Am Acad Dermatol. 2000;42:760-769.
17. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20(3 suppl):21-35.
18. Whitton ME, Ashcroft DM, Barrett CW, Gonzalez U. Interventions for vitiligo. Cochrane Database Syst Rev. 2006;1:CD003263.
19. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology. Arch Dermatol. 1999;135:1514-1521.
20. Falabella R. Surgical approaches for stable vitiligo. Dermatol Surg. 2005;31:1277-284.
21. Njoo MD, Westerhof W, Bos JD, Bossuyt PM. A systematic review of autologous transplantation methods in vitiligo. Arch Dermatol. 1998;134:1543-1549.